• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二酮酸降低热量摄入并改善高脂肪饮食喂养小鼠的非酒精性脂肪性肝病和肝淋巴血管功能障碍。

Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice.

机构信息

Department of Anatomy & Cell Biology, College of Medicine, Gachon University, Incheon 21936, Korea.

Functional Cellular Networks Laboratory, Lee Gil Ya Cancer and Diabetes Institute, College of Medicine, Gachon University, Incheon 21999, Korea.

出版信息

Mar Drugs. 2021 Aug 30;19(9):495. doi: 10.3390/md19090495.

DOI:10.3390/md19090495
PMID:34564157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8469311/
Abstract

Increased inflammation is the main pathophysiology of nonalcoholic fatty liver disease (NAFLD). Inflammation affects lymphatic vessel function that contributes to the removal of immune cells or macromolecules. Dysfunctional lymphatic vessels with decreased permeability are present in NAFLD. High-fat diet (HFD) is known to increase body weight, food intake, and inflammation in the liver. Previously, it was reported that extracts (ECE) decreased food intake or weight gain, and low-calorie diet and weight loss is known as a treatment for NAFLD. In this study, the effects of ECE and dieckol (DK)-which is one component of ECE that decreases inflammation and increases lymphangiogenesis and lymphatic drainage by controlling lymphatic permeability in high-fat diet (HFD)-fed mice-on weight gain and food intake were investigated. ECE and DK decreased weight gain and food intake in the HFD-fed mice. NAFLD activities such as steatosis, lobular inflammation, and ballooning were increased by HFD and attenuated by ECE and DK. The expression of inflammatory cytokines such as IL-6 and TNF-α and infiltration of M1 macrophages were increased by HFD, and they were decreased by ECE or DK. The signaling pathways of lymphangiogenesis, VEGFR-3, PI3K/pAKT, and pERK were decreased by HFD, and they were restored by either ECE or DK. The expression of VE-cadherin (which represents lymphatic junctional function) was increased by HFD, although it was restored by either ECE or DK. In conclusion, ECE and DK attenuated NAFLD by decreasing weight gain and food intake, decreasing inflammation, and increasing lymphangiogenesis, as well as modulating lymphatic vessel permeability.

摘要

炎症增加是非酒精性脂肪性肝病(NAFLD)的主要病理生理学机制。炎症会影响淋巴管的功能,从而影响免疫细胞或大分子的清除。NAFLD 存在功能失调的、通透性降低的淋巴管。高脂肪饮食(HFD)已知会增加体重、食物摄入和肝脏炎症。先前有报道称,提取物(ECE)可减少食物摄入或体重增加,而低热量饮食和减肥是治疗 NAFLD 的方法。在这项研究中,研究了 ECE 和二酮(DK)对高脂肪饮食(HFD)喂养的小鼠体重增加和食物摄入的影响。ECE 和 DK 可降低 HFD 喂养的小鼠的体重增加和食物摄入。ECE 和 DK 可减轻 HFD 引起的肝脂肪变性、小叶炎症和气球样变等 NAFLD 活动。ECE 或 DK 可降低 HFD 引起的炎症细胞因子(如 IL-6 和 TNF-α)的表达和 M1 巨噬细胞的浸润。HFD 会降低淋巴管生成的信号通路,如 VEGFR-3、PI3K/pAKT 和 pERK,而 ECE 或 DK 可恢复这些信号通路。HFD 会增加 VE-钙黏蛋白(代表淋巴管连接功能)的表达,但 ECE 或 DK 可恢复其表达。总之,ECE 和 DK 通过降低体重增加和食物摄入、减少炎症和增加淋巴管生成以及调节淋巴管通透性来减轻 NAFLD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/68434170cca8/marinedrugs-19-00495-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/d4c0b669d885/marinedrugs-19-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/0acffa06313e/marinedrugs-19-00495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/829aac2b3d9c/marinedrugs-19-00495-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/68434170cca8/marinedrugs-19-00495-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/d4c0b669d885/marinedrugs-19-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/0acffa06313e/marinedrugs-19-00495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/829aac2b3d9c/marinedrugs-19-00495-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8200/8469311/68434170cca8/marinedrugs-19-00495-g004.jpg

相似文献

1
Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice.二酮酸降低热量摄入并改善高脂肪饮食喂养小鼠的非酒精性脂肪性肝病和肝淋巴血管功能障碍。
Mar Drugs. 2021 Aug 30;19(9):495. doi: 10.3390/md19090495.
2
Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis.二碘水芹菜素通过降低 NLRP3 炎性小体和细胞焦亡减轻高脂饮食诱导的非酒精性脂肪性肝病。
Mar Drugs. 2021 May 30;19(6):318. doi: 10.3390/md19060318.
3
Extract Attenuates Endothelial Cell Dysfunction by Modulation of Inflammation and Brown Adipocyte Function in Perivascular Fat Tissue.提取物通过调节血管周围脂肪组织中的炎症和棕色脂肪细胞功能来减轻内皮细胞功能障碍。
Nutrients. 2019 Nov 15;11(11):2795. doi: 10.3390/nu11112795.
4
Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.裙带菜富含多酚的组分改善高脂饮食喂养小鼠的非酒精性脂肪性肝病
Mar Drugs. 2015 Nov 12;13(11):6866-83. doi: 10.3390/md13116866.
5
Dieckol-Attenuated High-Fat Diet Induced Muscle Atrophy by Modulating Muscular Deposition of Lipid Droplets.二萜酚通过调节脂滴在肌肉中的沉积减轻高脂饮食诱导的肌肉萎缩。
Nutrients. 2021 Sep 10;13(9):3160. doi: 10.3390/nu13093160.
6
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.白藜芦醇通过减少脂肪生成和炎症来减轻高脂喂养小鼠的肝脂肪变性。
Nutrition. 2014 Jul-Aug;30(7-8):915-9. doi: 10.1016/j.nut.2013.11.016. Epub 2013 Dec 4.
7
Dieckol Attenuated Glucocorticoid-Induced Muscle Atrophy by Decreasing NLRP3 Inflammasome and Pyroptosis.二酮酸可通过降低 NLRP3 炎症小体和细胞焦亡减轻糖皮质激素诱导的肌肉萎缩。
Int J Mol Sci. 2021 Jul 28;22(15):8057. doi: 10.3390/ijms22158057.
8
The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice.来自海带、大黄和麻黄的复方草药药物 GGEx18 可抑制高脂肪饮食诱导的肥胖小鼠的肝脂肪变性和纤维炎症。
J Ethnopharmacol. 2018 Oct 28;225:31-41. doi: 10.1016/j.jep.2018.06.034. Epub 2018 Jun 26.
9
Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.烟碱型乙酰胆碱受体 α7 亚基可改善非酒精性脂肪性肝病的能量平衡并抑制炎症。
Metabolism. 2018 Feb;79:52-63. doi: 10.1016/j.metabol.2017.11.002. Epub 2017 Nov 10.
10
Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.益母草水提物通过抑制游离脂肪酸诱导的 HepG2 细胞和高脂饮食喂养小鼠的非酒精性脂肪肝病。
Nutrients. 2017 Dec 25;10(1):20. doi: 10.3390/nu10010020.

引用本文的文献

1
Assessing Causal Relationships Between Periodontitis and Non-alcoholic Fatty Liver Disease: A Two-Sample Bidirectional Mendelian Randomisation Study.评估牙周炎和非酒精性脂肪性肝病之间的因果关系:两样本双向孟德尔随机研究。
Oral Health Prev Dent. 2024 May 28;22:189-202. doi: 10.3290/j.ohpd.b5395053.
2
Dietary Fat Composition Affects Hepatic Angiogenesis and Lymphangiogenesis in Hepatitis C Virus Core Gene Transgenic Mice.饮食脂肪组成影响丙型肝炎病毒核心基因转基因小鼠的肝脏血管生成和淋巴管生成。
Liver Cancer. 2022 Sep 16;12(1):57-71. doi: 10.1159/000525546. eCollection 2023 Feb.
3
Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.

本文引用的文献

1
Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis.二碘水芹菜素通过降低 NLRP3 炎性小体和细胞焦亡减轻高脂饮食诱导的非酒精性脂肪性肝病。
Mar Drugs. 2021 May 30;19(6):318. doi: 10.3390/md19060318.
2
Efficient aortic lymphatic drainage is necessary for atherosclerosis regression induced by ezetimibe.有效的主动脉淋巴引流对于依折麦布诱导的动脉粥样硬化消退是必要的。
Sci Adv. 2020 Dec 11;6(50). doi: 10.1126/sciadv.abc2697. Print 2020 Dec.
3
Critical Role of NFκB in the Pathogenesis of Non-alcoholic Fatty Liver Disease: A Widespread Key Regulator.
基于网络药理学、分子对接和分子动力学模拟探究疏肝消脂汤治疗非酒精性脂肪肝病的潜在机制。
PeerJ. 2022 Nov 10;10:e14171. doi: 10.7717/peerj.14171. eCollection 2022.
4
Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD.植物源生物活性化合物通过调节NLRP3炎性小体来治疗非酒精性脂肪性肝病。
Front Pharmacol. 2022 Aug 9;13:896899. doi: 10.3389/fphar.2022.896899. eCollection 2022.
5
Pyrogallol-Phloroglucinol-6, 6-Bieckol Restored Primary Cilia Length, Which Was Decreased by High-Fat Diet in Visceral Adipose Tissue, and Decreased Adipogenesis.连苯三酚-间苯三酚-6,6-二聚间苯三酚恢复了原发性纤毛长度,该长度因高脂饮食在内脏脂肪组织中缩短,并且减少了脂肪生成。
Int J Endocrinol. 2022 Apr 16;2022:8486965. doi: 10.1155/2022/8486965. eCollection 2022.
NFκB在非酒精性脂肪性肝病发病机制中的关键作用:一种广泛存在的关键调节因子
Curr Mol Med. 2021;21(6):495-505. doi: 10.2174/1566524020666201026162343.
4
Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System.氧化型低密度脂蛋白导致肝脏淋巴系统功能障碍。
Cell Mol Gastroenterol Hepatol. 2021;11(2):573-595. doi: 10.1016/j.jcmgh.2020.09.007. Epub 2020 Sep 19.
5
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH.基于证据的临床建议,用于管理 NAFLD 和 NASH 的营养和饮食减肥策略。
Clin Mol Hepatol. 2020 Oct;26(4):383-400. doi: 10.3350/cmh.2020.0067. Epub 2020 Jul 17.
6
Mechanisms Ensuring Endothelial Junction Integrity Beyond VE-Cadherin.除血管内皮钙黏蛋白外确保内皮细胞连接完整性的机制
Front Physiol. 2020 May 21;11:519. doi: 10.3389/fphys.2020.00519. eCollection 2020.
7
The Phlorotannin-Rich Fraction of Extract Attenuated the Expressions of the Markers Related with Inflammation and Leptin Resistance in Adipose Tissue.提取物中富含间苯二酚单宁的部分减弱了脂肪组织中与炎症和瘦素抵抗相关标志物的表达。
Int J Endocrinol. 2020 Mar 7;2020:9142134. doi: 10.1155/2020/9142134. eCollection 2020.
8
Nonalcoholic Steatohepatitis: A Review.非酒精性脂肪性肝炎:综述。
JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.
9
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease.佛手多酚改善非酒精性脂肪肝病小鼠的血脂异常及病理生理特征。
Sci Rep. 2020 Feb 13;10(1):2565. doi: 10.1038/s41598-020-59485-3.
10
Extract Attenuates Endothelial Cell Dysfunction by Modulation of Inflammation and Brown Adipocyte Function in Perivascular Fat Tissue.提取物通过调节血管周围脂肪组织中的炎症和棕色脂肪细胞功能来减轻内皮细胞功能障碍。
Nutrients. 2019 Nov 15;11(11):2795. doi: 10.3390/nu11112795.